| Diminished efficacy of programmed death-(ligand) 1 inhibition in STK11-and KEAP1-mutant lung adenocarcinoma is affected by KRAS mutation status B Ricciuti, KC Arbour, JJ Lin, A Vajdi, N Vokes, L Hong, J Zhang, ... Journal of Thoracic Oncology 17 (3), 399-410, 2022 | 185 | 2022 |
| Immune checkpoint inhibitor therapy in patients with preexisting inflammatory bowel disease H Abu-Sbeih, DM Faleck, B Ricciuti, RB Mendelsohn, AR Naqash, ... Journal of Clinical Oncology 38 (6), 576, 2020 | 153 | 2020 |
| Molecular mechanisms of acquired resistance to MET tyrosine kinase inhibitors in patients with MET exon 14–mutant NSCLC G Recondo, M Bahcall, LF Spurr, J Che, B Ricciuti, GC Leonardi, YC Lo, ... Clinical Cancer Research 26 (11), 2615-2625, 2020 | 143 | 2020 |
| Association of high tumor mutation burden in non–small cell lung cancers with increased immune infiltration and improved clinical outcomes of PD-L1 blockade across PD-L1 … B Ricciuti, X Wang, JV Alessi, H Rizvi, NR Mahadevan, YY Li, A Polio, ... JAMA oncology 8 (8), 1160-1168, 2022 | 141 | 2022 |
| Impact of DNA damage response and repair (DDR) gene mutations on efficacy of PD-(L) 1 immune checkpoint inhibition in non–small cell lung cancer B Ricciuti, G Recondo, LF Spurr, YY Li, G Lamberti, D Venkatraman, ... Clinical cancer research 26 (15), 4135-4142, 2020 | 112 | 2020 |
| Beyond EGFR, ALK and ROS1: current evidence and future perspectives on newly targetable oncogenic drivers in lung adenocarcinoma G Lamberti, E Andrini, M Sisi, A Rizzo, C Parisi, A Di Federico, ... Critical reviews in oncology/hematology 156, 103119, 2020 | 110 | 2020 |
| Clinical outcomes and toxic effects of single-agent immune checkpoint inhibitors among patients aged 80 years or older with cancer: a multicenter international cohort study CA Nebhan, A Cortellini, W Ma, T Ganta, H Song, F Ye, R Irlmeier, ... JAMA oncology 7 (12), 1856-1861, 2021 | 85 | 2021 |
| Clinicopathological and genomic correlates of programmed cell death ligand 1 (PD-L1) expression in nonsquamous non-small-cell lung cancer G Lamberti, LF Spurr, Y Li, B Ricciuti, G Recondo, R Umeton, M Nishino, ... Annals of Oncology 31 (6), 807-814, 2020 | 85 | 2020 |
| The social structuring of the digital gap in a developing country. The impact of computer and internet access opportunities on internet use in Thailand J Lopez-Sintas, G Lamberti, J Sukphan Technology in Society 63, 101433, 2020 | 69 | 2020 |
| ROS1-rearranged non–small-cell lung cancer is associated with a high rate of venous thromboembolism: analysis from a phase II, prospective, multicenter, two-arms trial (METROS) R Chiari, B Ricciuti, L Landi, AM Morelli, A Delmonte, G Spitaleri, ... Clinical Lung Cancer 21 (1), 15-20, 2020 | 63 | 2020 |
| Morphological factors related to nodal metastases in neuroendocrine tumors of the appendix: a multicentric retrospective study N Brighi, S La Rosa, G Rossi, F Grillo, S Pusceddu, M Rinzivillo, F Spada, ... Annals of surgery 271 (3), 527-533, 2020 | 60 | 2020 |
| The evolving landscape of immunotherapy in small-cell lung cancer: a focus on predictive biomarkers F Gelsomino, G Lamberti, C Parisi, L Casolari, B Melotti, F Sperandi, ... Cancer Treatment Reviews 79, 101887, 2019 | 55 | 2019 |
| The role of mTOR in neuroendocrine tumors: future cornerstone of a winning strategy? G Lamberti, N Brighi, I Maggio, L Manuzzi, C Peterle, V Ambrosini, C Ricci, ... International journal of molecular sciences 19 (3), 747, 2018 | 54 | 2018 |
| Effect of hinged lamellar keratotomy on postkeratoplasty eyes M Busin, RC Arffa, L Zambianchi, G Lamberti, A Sebastiani Ophthalmology 108 (10), 1845-1851, 2001 | 52 | 2001 |
| The mechanisms of PD-L1 regulation in non-small-cell lung cancer (NSCLC): which are the involved players? G Lamberti, M Sisi, E Andrini, A Palladini, F Giunchi, PL Lollini, ... Cancers 12 (11), 3129, 2020 | 49 | 2020 |
| Efficacy of diclofenac eyedrops in preventing postoperative inflammation and long-term cystoid macular edema PE Gallenga, L Mastropasqua, L Lobefolo, DC Loggia, E Ballone, ... Journal of Cataract & Refractive Surgery 23 (8), 1183-1189, 1997 | 45 | 1997 |
| The functioning side of the pancreas: a review on insulinomas I Maggio, V Mollica, N Brighi, G Lamberti, L Manuzzi, AD Ricci, ... Journal of endocrinological investigation 43, 139-148, 2020 | 44 | 2020 |
| Circadian changes of intraocular pressure and ocular perfusion pressure after timolol or latanoprost in Caucasians with normal-tension glaucoma C Costagliola, F Parmeggiani, G Virgili, G Lamberti, C Incorvaia, P Perri, ... Graefe's Archive for Clinical and Experimental Ophthalmology 246, 389-396, 2008 | 44 | 2008 |
| Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC MV Negrao, HA Araujo, G Lamberti, AJ Cooper, NS Akhave, T Zhou, ... Cancer discovery 13 (7), 1556-1571, 2023 | 43 | 2023 |
| Biliary stone disease in patients receiving somatostatin analogs for neuroendocrine neoplasms. A retrospective observational study N Brighi, G Lamberti, I Maggio, L Manuzzi, C Ricci, R Casadei, D Santini, ... Digestive and liver disease 51 (5), 689-694, 2019 | 40 | 2019 |
